Stock chart
Ticker: AIMT Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2020-10-15 2020-10-13 B Purchase

Societe des Produits Nestle S.A.

Major owner
10,681,704 +83.9%
34.50
368,518,788 USD
10,681,704 +83.9% 34.50 368,518,788 USD
2020-10-15 2020-10-13 B Purchase

Societe des Produits Nestle S.A.

Major owner
43,435,583 +inf%
34.50
1,498,527,614 USD
43,435,583 +inf% 34.50 1,498,527,614 USD
2020-03-19 2020-03-18 B Purchase

ENRIGHT PATRICK G

Non-Executive Director
16,213 +29.8%
11.06
179,345 USD
16,213 +29.8% 11.06 179,345 USD
2020-03-19 2020-03-17 B Purchase

ENRIGHT PATRICK G

Non-Executive Director
8,787 +19.3%
11.50
101,051 USD
8,787 +19.3% 11.50 101,051 USD
2020-03-19 2020-03-17 B Purchase

ENRIGHT PATRICK G

Non-Executive Director
100,000 +1.7%
11.40
1,139,650 USD
100,000 +1.7% 11.40 1,139,650 USD
2020-03-17 2020-03-13 B Purchase

Oxtoby Andrew

Chief Commercial Officer

Officer
3,000 +13.6%
14.76
44,266 USD
3,000 +13.6% 14.76 44,266 USD
2020-03-12 2020-03-12 B Purchase

BJERKHOLT ERIC

Chief Financial Officer

Officer
1,000 +2.4%
15.10
15,100 USD
1,000 +2.4% 15.10 15,100 USD
2020-03-10 2020-03-10 B Purchase

Dallas Jayson Donald Alexander

President and CEO

Executive Director
2,665 +2.2%
18.74
49,934 USD
2,665 +2.2% 18.74 49,934 USD
2020-03-10 2020-03-09 B Purchase

BJERKHOLT ERIC

Chief Financial Officer

Officer
1,000 +2.4%
18.97
18,970 USD
1,000 +2.4% 18.97 18,970 USD
2020-04-24 2020-02-07 B Purchase

Societe des Produits Nestle S.A.

Major owner
525,634 +inf%
319.68
168,032,049 USD
525,634 +inf% 319.68 168,032,049 USD
2020-04-24 2020-02-07 B Purchase

Societe des Produits Nestle S.A.

Major owner
1,000,000 +8.5%
31.97
31,970,000 USD
1,000,000 +8.5% 31.97 31,970,000 USD
2020-01-21 2020-01-16 PS Planned sale

Sheehy Douglas T.

See Remarks

400 -0.9%
37.00
14,800 USD
400 -0.9% 37.00 14,800 USD
2020-01-03 2020-01-02 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer

20,000 -48.5%
35.00
700,038 USD
20,000 -48.5% 35.00 700,038 USD
2019-12-30 2019-12-26 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
10,000 -18.0%
33.03
330,322 USD
10,000 -18.0% 33.03 330,322 USD
2019-12-11 2019-12-09 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer

Officer
20,000 -48.5%
30.04
600,716 USD
20,000 -48.5% 30.04 600,716 USD
2019-09-20 2019-09-18 B Purchase

BJERKHOLT ERIC

Chief Financial Officer

1,550 +4.8%
22.57
34,977 USD
1,550 +4.8% 22.57 34,977 USD
2020-04-24 2018-11-28 B Purchase

Nestle Health Science US Holdings, Inc.

Major owner
3,237,529 +38.1%
30.27
98,000,003 USD
3,237,529 +38.1% 30.27 98,000,003 USD
2018-11-21 2018-11-19 S Sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
40,000 -81.0%
30.04
1,201,600 USD
40,000 -81.0% 30.04 1,201,600 USD
2018-11-19 2018-11-19 B Purchase

Dallas Jayson Donald Alexander

President and CEO

Executive Director
50 +0.1%
27.56
1,378 USD
50 +0.1% 27.56 1,378 USD
2018-11-19 2018-11-19 B Purchase

Dallas Jayson Donald Alexander

President and CEO

Executive Director
3,600 +6.0%
27.56
99,209 USD
3,600 +6.0% 27.56 99,209 USD
2018-06-14 2018-06-13 PP Planned purchase

BJERKHOLT ERIC

Chief Financial Officer

1,600 +8.9%
30.41
48,663 USD
1,600 +8.9% 30.41 48,663 USD
2018-06-13 2018-06-11 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
29,457 -8.5%
30.83
908,301 USD
29,457 -8.5% 30.83 908,301 USD
2018-06-08 2018-06-08 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
42,106 -11.8%
30.70
1,292,511 USD
42,106 -11.8% 30.70 1,292,511 USD
2018-06-08 2018-06-07 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
500 -0.2%
31.58
15,790 USD
500 -0.2% 31.58 15,790 USD
2018-06-08 2018-06-07 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
32,098 -9.2%
30.95
993,321 USD
32,098 -9.2% 30.95 993,321 USD
2018-06-08 2018-06-06 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
30,465 -8.8%
31.20
950,371 USD
30,465 -8.8% 31.20 950,371 USD
2018-06-05 2018-06-05 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
38,825 -11.0%
31.83
1,235,835 USD
38,825 -11.0% 31.83 1,235,835 USD
2018-06-05 2018-06-04 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
2,612 -0.8%
32.74
85,519 USD
2,612 -0.8% 32.74 85,519 USD
2018-06-05 2018-06-04 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
62,740 -16.5%
31.84
1,997,836 USD
62,740 -16.5% 31.84 1,997,836 USD
2018-06-05 2018-06-01 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
2,498 -0.8%
33.19
82,899 USD
2,498 -0.8% 33.19 82,899 USD
2018-06-05 2018-06-01 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
58,699 -15.6%
32.59
1,913,094 USD
58,699 -15.6% 32.59 1,913,094 USD
2018-05-24 2018-05-22 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
1,648 -4.7%
33.00
54,384 USD
1,648 -4.7% 33.00 54,384 USD
2018-05-24 2018-05-22 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
1,648 -4.7%
33.00
54,384 USD
1,648 -4.7% 33.00 54,384 USD
2018-03-06 2018-03-05 PS Planned sale

Sheehy Douglas T.

See Remarks

700 -2.1%
36.60
25,618 USD
700 -2.1% 36.60 25,618 USD
2018-03-06 2018-03-05 PS Planned sale

Sheehy Douglas T.

See Remarks

948 -2.8%
35.52
33,674 USD
948 -2.8% 35.52 33,674 USD
2018-03-06 2018-03-05 PS Planned sale

Sheehy Douglas T.

See Remarks

1,875 -5.5%
37.00
69,375 USD
1,875 -5.5% 37.00 69,375 USD
2018-03-05 2018-03-01 PS Planned sale

Rozenman Mary M.

See Remarks

1,807 -93.3%
33.10
59,812 USD
1,807 -93.3% 33.10 59,812 USD
2020-04-24 2018-02-26 B Purchase

Nestle Health Science US Holdings, Inc.

Major owner
937,500 +12.4%
32.00
30,000,000 USD
937,500 +12.4% 32.00 30,000,000 USD
2018-02-26 2018-02-26 B Purchase

BJERKHOLT ERIC

Chief Financial Officer

Officer
3,125 +62.5%
32.00
100,000 USD
3,125 +62.5% 32.00 100,000 USD
2018-02-26 2018-02-26 B Purchase

FALBERG KATHRYN E

Non-Executive Director
30,000 +31.6%
32.00
960,000 USD
30,000 +31.6% 32.00 960,000 USD
2018-02-26 2018-02-26 B Purchase

Iwicki Mark T

Non-Executive Director
9,375 +46.9%
32.00
300,000 USD
9,375 +46.9% 32.00 300,000 USD
2018-02-26 2018-02-22 B Purchase

ENRIGHT PATRICK G

Non-Executive Director Major owner
15,593 +214.3%
32.00
498,976 USD
15,593 +214.3% 32.00 498,976 USD
2018-02-26 2018-02-22 B Purchase

Tammenoms Bakker Juliet

Major owner
9,375 +128.8%
32.00
300,000 USD
9,375 +128.8% 32.00 300,000 USD
2018-02-07 2018-02-05 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
1,648 -100.0%
35.87
59,114 USD
1,648 -100.0% 35.87 59,114 USD
2018-02-05 2018-02-01 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
4,292 -97.1%
35.58
152,703 USD
4,292 -97.1% 35.58 152,703 USD
2018-02-05 2018-02-01 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
2,300 -34.2%
34.95
80,385 USD
2,300 -34.2% 34.95 80,385 USD
2018-01-26 2018-01-24 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
1,875 -100.0%
38.15
71,531 USD
1,875 -100.0% 38.15 71,531 USD
2018-01-16 2018-01-16 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer

Officer
9,933 -100.0%
40.00
397,320 USD
9,933 -100.0% 40.00 397,320 USD
2018-01-16 2018-01-12 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer

Officer
26,784 -100.0%
40.00
1,071,360 USD
26,784 -100.0% 40.00 1,071,360 USD
2018-01-08 2018-01-04 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
1,648 -100.0%
37.33
61,520 USD
1,648 -100.0% 37.33 61,520 USD
2018-01-04 2018-01-02 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
600 -100.0%
37.75
22,652 USD
600 -100.0% 37.75 22,652 USD
2018-01-04 2018-01-02 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
24,400 -97.6%
37.12
905,716 USD
24,400 -97.6% 37.12 905,716 USD
2018-01-04 2018-01-02 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
300 -1.2%
37.86
11,359 USD
300 -1.2% 37.86 11,359 USD
2018-01-04 2018-01-02 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
24,700 -49.4%
37.13
917,022 USD
24,700 -49.4% 37.13 917,022 USD
2018-01-04 2018-01-02 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
599 -1.2%
37.78
22,629 USD
599 -1.2% 37.78 22,629 USD
2018-01-04 2018-01-02 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
24,401 -32.5%
37.12
905,811 USD
24,401 -32.5% 37.12 905,811 USD
2018-01-04 2018-01-02 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
1,601 -92.5%
37.08
59,367 USD
1,601 -92.5% 37.08 59,367 USD
2018-01-04 2018-01-02 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
4,990 -74.3%
37.12
185,223 USD
4,990 -74.3% 37.12 185,223 USD
2017-12-29 2017-12-27 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer

3,283 -100.0%
40.00
131,320 USD
3,283 -100.0% 40.00 131,320 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

3,600 -96.5%
39.15
140,949 USD
3,600 -96.5% 39.15 140,949 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

6,400 -63.2%
38.73
247,848 USD
6,400 -63.2% 38.73 247,848 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

1,200 -10.6%
39.28
47,134 USD
1,200 -10.6% 39.28 47,134 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

8,800 -43.7%
38.83
341,663 USD
8,800 -43.7% 38.83 341,663 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

700 -3.4%
39.26
27,479 USD
700 -3.4% 39.26 27,479 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

4,310 -17.1%
38.80
167,239 USD
4,310 -17.1% 38.80 167,239 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

1,500 -5.6%
39.23
58,847 USD
1,500 -5.6% 39.23 58,847 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

11,000 -29.2%
38.82
427,043 USD
11,000 -29.2% 38.82 427,043 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

1,500 -3.8%
39.25
58,875 USD
1,500 -3.8% 39.25 58,875 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

11,000 -21.9%
38.83
427,115 USD
11,000 -21.9% 38.83 427,115 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

1,800 -3.5%
39.23
70,605 USD
1,800 -3.5% 39.23 70,605 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

10,700 -17.1%
38.82
415,322 USD
10,700 -17.1% 38.82 415,322 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

1,500 -2.3%
39.25
58,878 USD
1,500 -2.3% 39.25 58,878 USD
2017-12-28 2017-12-26 PS Planned sale

Rozenman Mary M.

See Remarks

11,000 -14.6%
38.83
427,089 USD
11,000 -14.6% 38.83 427,089 USD
2017-12-28 2017-12-26 PS Planned sale

Sheehy Douglas T.

See Remarks

1,875 -100.0%
39.44
73,950 USD
1,875 -100.0% 39.44 73,950 USD
2017-12-06 2017-12-04 PS Planned sale

Sheehy Douglas T.

See Remarks

1,906 -100.0%
38.66
73,686 USD
1,906 -100.0% 38.66 73,686 USD